Published in J Gen Virol on October 01, 2008
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell (2014) 1.58
Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators. PLoS Pathog (2016) 1.39
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol (2011) 1.17
Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol (2011) 1.09
Multifaceted evasion of the interferon response by cytomegalovirus. J Interferon Cytokine Res (2009) 1.06
Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir. Antimicrob Agents Chemother (2008) 1.05
cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells. PLoS Pathog (2016) 0.95
Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. J Virol (2009) 0.95
Human cytomegalovirus and autoimmune disease. Biomed Res Int (2014) 0.90
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol (2013) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J Virol (2013) 0.89
The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol (2013) 0.87
Ubiquitination-mediated regulation of interferon responses. Growth Factors (2012) 0.86
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86
HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms. Virus Res (2012) 0.83
ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J (2012) 0.80
Cytomegalovirus infection impairs immunosuppressive and antimicrobial effector functions of human multipotent mesenchymal stromal cells. Mediators Inflamm (2014) 0.79
Broad and potent antiviral activity of the NAE inhibitor MLN4924. Sci Rep (2016) 0.79
Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS One (2013) 0.78
Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS One (2011) 0.77
The carboxy terminal region of the human cytomegalovirus immediate early 1 (IE1) protein disrupts type II inteferon signaling. Viruses (2014) 0.76
HATs on for drug resistance. Cell Host Microbe (2011) 0.76
A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection. PLoS Pathog (2015) 0.76
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists. Vaccines (Basel) (2016) 0.75
Abrogation of the interferon response promotes more efficient human cytomegalovirus replication. J Virol (2014) 0.75
VP8, the Major Tegument Protein of Bovine Herpesvirus 1, Interacts with Cellular STAT1 and Inhibits Interferon Beta Signaling. J Virol (2016) 0.75
Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression. Front Immunol (2017) 0.75
Human Cytomegalovirus IE2 86 kDa Protein Induces STING Degradation and Inhibits cGAMP-Mediated IFN-β Induction. Front Microbiol (2017) 0.75
Host immune system gene targeting by a viral miRNA. Science (2007) 5.10
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
Decoding human cytomegalovirus. Science (2012) 2.98
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood (2005) 2.40
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry (2012) 1.66
Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int (2009) 1.65
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest (2004) 1.58
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood (2010) 1.38
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Rapid replacement of endemic measles virus genotypes. J Gen Virol (2002) 1.25
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol (2011) 1.17
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17
Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2. J Virol (2008) 1.16
Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. J Clin Virol (2004) 1.11
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 1.11
Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol (2005) 1.06
Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res (2002) 1.04
CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells. J Virol (2013) 1.03
The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol (2008) 1.03
Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog (2011) 1.00
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol (2004) 0.99
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scler (2010) 0.98
Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus. FEBS Lett (2008) 0.98
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. PLoS Pathog (2012) 0.97
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology (2009) 0.95
c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology (2011) 0.94
"Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. J Immunol (2013) 0.92
Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol (2012) 0.91
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol (2008) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol Immunol (2011) 0.89
The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int (2014) 0.87
Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem (2005) 0.87
The crucial role of molecular diagnostics. Dtsch Arztebl Int (2014) 0.87
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86
Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol (2008) 0.86
Complete genome sequence of the english isolate of rat cytomegalovirus (Murid herpesvirus 8). J Virol (2012) 0.85
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci U S A (2013) 0.85
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response. J Immunol (2014) 0.85
Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? Int Immunopharmacol (2004) 0.84
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol (2014) 0.84
The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol (2012) 0.82
The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cell Microbiol (2006) 0.82
Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation. Blood (2013) 0.82
A natural tapasin isoform lacking exon 3 modifies peptide loading complex function. Eur J Immunol (2013) 0.80
HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum Immunol (2003) 0.80
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. J Immunol Methods (2012) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS One (2013) 0.78
High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol J (2009) 0.77
Data-warehousing of protein-protein interactions indicates that pathogens preferentially target hub and bottleneck proteins. Front Microbiol (2013) 0.77
Checks and balances between human cytomegalovirus replication and indoleamine-2,3-dioxygenase. J Gen Virol (2013) 0.77
Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS One (2011) 0.77
Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention. Future Microbiol (2012) 0.76
[University medical education in transition]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.76
Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008. Virus Genes (2013) 0.76
A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus. J Immunol Methods (2011) 0.75
Noncontrolled trial of monovalent AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) in long-term dialysis patients and transplant recipients. Am J Kidney Dis (2011) 0.75
RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production. Cell Physiol Biochem (2016) 0.75